New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like A previously unknown post-COVID syndrome found May 9, 2024 New study reveals how tumor cells evade the immune system November 6, 2024 PCOS patients can achieve same birth rates with treatment December 12, 2023